title: Frequency and determinants of the postthrombotic syndrome after venous thromboembolism.
abstract: OBJECTIVE
  Postthrombotic syndrome (PTS) is the most common complication of deep venous thrombosis (DVT). Identifying which patients are at high risk of developing PTS would help improve the management of patients with DVT and allow physicians to provide patients with individualized information on their expected prognosis. This review discusses the knowledge gained from key studies over the last decade on the incidence and determinants of PTS, with special emphasis on published studies from the last 2 years.
  
  
  RESULTS
  About a third to half of DVT patients will develop PTS, in most cases within 1-2 years of acute DVT. Important risk factors for PTS appear to be ipsilateral recurrence of DVT, poor quality of initial anticoagulation for the treatment of DVT and increased body mass index.
  
  
  CONCLUSIONS
  Preventing DVT recurrence by providing adequate intensity and duration of anticoagulation for the initial DVT and using effective thromboprophylaxis in high-risk settings is likely to reduce the frequency of PTS. Despite some advances in identifying risk factors for PTS, however, it is still not possible to reliably predict an individual patient's risk of developing PTS after an episode of DVT. Further studies of clinical determinants and biological markers of increased risk of PTS are needed to ultimately improve long-term prognosis after DVT.
authors.affiliation: Centre for Clinical Epidemiology and Community Studies, SMBD Jewish General Hospital, and Department of Medicine, McGill University, Montreal, Quebec, Canada. susan.kahn@mcgill.ca
authors.forename: Susan R
authors.initials: SR
authors.lastname: Kahn
mesh_terms: D015415:Biomarkers; D006801:Humans; D015994:Incidence; D011186:Postphlebitic Syndrome / Q000453:epidemiology* / Q000209:etiology* / Q000517:prevention & control; D012307:Risk Factors; D020246:Venous Thrombosis / Q000150:complications*
chemical_list: D015415:Biomarkers